€250k windfall for GW as Sativex is approved in Italy.
Gw Pharmaceutical’s have just won a €250k windfall as they have been given approval for their trademark cannabis tincture Sativex.
The media coverage has tried again to say that Sativex is a cannabis -based medicine, which simply is not true. Sativex is not a cannabis BASED medicine, sativex IS cannabis. It-is made from the whole plant and contains all the cannabinoids from the plants that GW grow not just the THC and CBD that is on the label.
GW grow the very same plant which would be illegal for anyone else to grow, even those with MS who would be eligible for sativex would be considered criminal’s if they were to grow cannabis themselves.
Full market arthorisation has been given to sativex to treat moderate to severe spasticity in MS. Italy becomes the 21st country to approve Sativex for treatment in MS. GW share holders are set to make some money off of a plant which only GW are allowed to grow.
This is a picture of one of GW’s cannabis plants that sativex is made out of.
I fail to see how herbal cannabis has no medicinal value, as that is exactly what sativex is made out of. But then how would a pharmaceutical company like GW profit from the healing power of cannabis if everyone was allowed to grow it?